About Vicore Pharma

Vicore Pharma is a pharmaceutical company dedicated to developing innovative medicines for severe lung disorders. It develops drugs that act through the AT2 receptor. The company’s drug candidate C21 aims to improve the treatment of idiopathic pulmonary fibrosis, a rare disease for which C21 has been granted orphan drug designation both in the EU and the US. In addition, C21 is explored pre-clinically in a number of rare diseases where the AT2 receptor plays an important role. The company is bas

Company Highlights
Year Founded

2009

icon-altEmployees

37

Location (HQ)

SWE

Since Last Funding

1 year 3 months

Monthly Website Visitors

13.4K

icon-altTotal Investment Amt

$48M

Last Funding Round

Post Ipo Equity

icon-altMoM Headcount Growth

2.77%

icon-altYoY Headcount Growth

2.77%

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Similar Companies

Pharmaceutical

Biopharma

Pharmaceutical Manufacturing

Pharmaceuticals